Efficacy of oxytocin versus carbetocin in prevention of postpartum hemorrhage after cesarean section under general anesthesia: a prospective randomized clinical trial

References

• Vahiddastjerdy M, Changizi N, Habibollahi A, et al. Maternal mortality ratio and causes of death in IRI between 2009 and 2012. J Fam Reprod Health. 2016;10(3):154–162.
   PubMedGoogle Scholar
• Berg CJ, Atrash HK, Koonin LM, et al. Pregnancy-related mortality in the United States, 1987–1990. Obstet Gynecol. 1996;88(2):161–167.
   PubMed Web of Science ®Google Scholar
• AbouZahr C. Antepartum and postpartum haemorrhage. Global Burden Dis Injury Series. 1998;3:165–190.
   Google Scholar
• American College of Obstetricians and Gynecologists. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists Number 76, October 2006: postpartum hemorrhage. Obstet Gynecol. 2006;108(4):1039–1047.
   PubMedGoogle Scholar
• Baskett TF. Complications of the third stage of labour. In: Essential management of obstetrical emergencies. 3rd ed. Bristol: Clinical Press; 1999. p. 196–201.
   Google Scholar
• Attilakos G, Psaroudakis D, Ash J, et al. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG. 2010;117(8):929–936.
   PubMed Web of Science ®Google Scholar
• Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012;2:CD005457.
   Google Scholar
• Samimi M, Imani-Harsini A, Abedzadeh-Kalahroudi M. Carbetocin vs. syntometrine in prevention of postpartum hemorrhage: a Double Blind Randomized Control Trial. Iran Red Crescent Med J. 2013;15(9):817–822.
   PubMed Web of Science ®Google Scholar
• Choy CM, Lau WC, Tam WH, et al. A randomised controlled trial of intramuscular syntometrine and intravenous oxytocin in the management of the third stage of labour. BJOG. 2002;109(2):173–177.
   PubMed Web of Science ®Google Scholar
• Prendiville W, Elbourne D, Chalmers I. The effects of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials. BJOG. 1988;95(1):3–16.
   Web of Science ®Google Scholar
• Dumoulin JG. A reappraisal of the use of ergometrine. J Obstet Gynaecol. 1981;1(3):178–181.
   Google Scholar
• Cunnigham F, Leveno K, Bloom S, et al. Williams obstetrics. 24th ed; 2014; p. 1130.
   Google Scholar
• Leung S, Ng P, Wong W, et al. A randomised trial of carbetocin versus syntometrine in the management of the third stage of labour. BJOG Int J Obstet Gynaecol. 2006;113(12):1459–1464.
   PubMed Web of Science ®Google Scholar
• Larciprete G, Montagnoli C, Frigo M, et al. Carbetocin versus oxytocin in caesarean section with high risk of post-partum haemorrhage. J Prenat Med. 2013;7(1):12–18.
   PubMedGoogle Scholar
• Begum P, Shaha DR, Mahbuba, et al. Carbetocin versus oxytocin for the Prevention of postpartum haemorrhage. Faridpur Med Coll J. 2016;10(2):76–83.
   Google Scholar
• Atke A, Vilhardt H. Uterotonic activity and myometrial receptor affinity of 1-deamino-1-carba-2-tyrosine(O-methyl)-oxytocin. Acta Endocrinol (Copenh). 1987;115(1):155–160.
   PubMedGoogle Scholar
• Gizzo S, Patrelli TS, Gangi SD, et al. Which uterotonic is better to prevent the postpartum hemorrhage? Latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review. Reprod Sci. 2013;20(9):1011–1019.
   PubMed Web of Science ®Google Scholar
• Manrique Muñoz S, Munar Bauzà F, Francés González S, et al. Update on the use of uterotonic agents. Rev Esp Anestesiol Reanim. 2012;59(2):91–97 (Article in Spanish).
   PubMedGoogle Scholar
• Amsalem H, Aldrich CJ, Oskamp M, et al. Postpartum uterine response to oxytocin and carbetocin. J Reprod Med. 2014;59(3–4):167–173.
   PubMed Web of Science ®Google Scholar
• Moertl MG, Friedrich S, Kraschl J, et al. Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial. BJOG. 2011;118(11):1349–1356.
   PubMed Web of Science ®Google Scholar
• Reyes OA, Gonzalez GM. Carbetocin versus oxytocin for prevention of postpartum hemorrhage in patients with severe preeclampsia: a double-blind randomized controlled trial. J Obstet Gynaecol Can. 2011;33(11):1099–1104.
   PubMedGoogle Scholar
• Anandakrishnan S, Balki M, Farine D, et al. Carbetocin at elective cesarean delivery: a randomized controlled trial to determine the effective dose, Part 2. Can J Anesth. 2013;60(11):1054–1060.
   PubMed Web of Science ®Google Scholar
• Cordovani D, Balki M, Farine D, et al. Carbetocin at elective cesarean delivery: a randomized controlled trial to determine the effective dose. Can J Anesth. 2012;59(8):751–757.
   PubMed Web of Science ®Google Scholar
• Triopon G, Goron A, Agenor J, et al. Use of carbetocin in prevention of uterine atony during cesarean section. Comparison with oxytocin. Gynecol Obstet Fertil. 2010;38(12):729–734. (Article in French).
   PubMedGoogle Scholar
• Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012;4:CD005457.
   PubMed Web of Science ®Google Scholar
• Boucher M, Nimrod CA, Tawagi GF, et al. Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery: a double-blind randomized trial. J Obstet Gynaecol Can. 2004;26(5):481–488.
   PubMedGoogle Scholar
• Higgins L, Mechery J, Tomlinson AJ. Does carbetocin for prevention of postpartum haemorrhage at caesarean section provide clinical or financial benefit compared with oxytocin? J Obstet Gynaecol. 2011;31(8):732–739.
   PubMedGoogle Scholar
• Peters NC, Duvekot JJ. Carbetocin for the prevention of postpartum hemorrhage: a systematic review. Obstet Gynecol Surv. 2009;64(2):129–135.
   PubMed Web of Science ®Google Scholar
• Borruto F, Treisser A, Comparetto C. Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial. Arch Gynecol Obstet. 2009;280(5):707–712.
   PubMed Web of Science ®Google Scholar
• Rath W. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin. Eur J Obstet Gynecol Reprod Biol. 2009;147(1):15–20.
   PubMed Web of Science ®Google Scholar